APPLICATION
ANDA214337
TYPE
ANDA
ORIGINAL APPROVAL
2023-06-09
LATEST ACTION
2024-10-08
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
SUGAMMADEX SODIUMPrescription
SUGAMMADEX SODIUM EQ 500MG BASE/5ML (EQ 100MG BASE/ML) · SOLUTION · INTRAVENOUS
SUGAMMADEX SODIUMPrescription
SUGAMMADEX SODIUM EQ 200MG BASE/2ML (EQ 100MG BASE/ML) · SOLUTION · INTRAVENOUS
Approval history
2024-10-08Labeling · Supplement 2 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.